Copd and Asthma Devices Market Analysis and Forecast 2015

COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals with breathing problems. These devices deliver an optimum dosage of medication directly to the site of action, preventing inflammation and constriction of the airways and minimizing symptoms. These devices include inhalers and nebulizers, most of which are handheld and portable.

Technavio's analysts forecast the global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global COPD and asthma devices market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following COPD and asthma devices:

• Inhalers

• Nebulizers

Technavio's report, Global COPD and Asthma Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.

Browse Detail Report With TOC @ http://hexareports.com/report/global-copd-and-asthma-devices-market/details

Key regions

• Americas

• APAC

• EMEA

Key vendors

• Consort Medical

• Gerresheimer

• Nypro

• Philips Healthcare

• RPC Bramlage

Other prominent vendors

• Aerogen

• Airon

• Allied Healthcare

• AstraZeneca

• Boehringer Ingelheim

• Briggs Healthcare

• Cardinal Health

• Clement Clarke International

• DeVilbiss Healthcare

• Drive Medical

• GlaxoSmithKline

• Heyer Medical

• Invacare

• Omron Healthcare

• PARI Medical

• Salter Labs

• Smart Inhaler

• Sunovion Pharmaceuticals

• Teleflex

• Vortran Medical

Market driver

• Increased prevalence of respiratory disorders

• For a...